Thomas Wittlinger
Overview
Explore the profile of Thomas Wittlinger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
363
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Veltmann C, Duncker D, Doering M, Gummadi S, Robertson M, Wittlinger T, et al.
Eur Heart J
. 2024 Jun;
45(30):2771-2781.
PMID: 38864173
Background And Aims: In patients with de novo heart failure with reduced ejection fraction (HFrEF), improvement of left ventricular ejection fraction (LVEF) is expected to occur when started on guideline-recommended...
2.
Majnaric Trtica L, Volaric M, Kurevija T, Mihaljevic S, Krivdic Dupan Z, Wittlinger T
BMC Geriatr
. 2023 Dec;
23(1):801.
PMID: 38049734
Background: Aging is associated with many personal, social, and environmental challenges that increase the risk of loneliness. Loneliness is a painful emotional experience associated with a perceived lack of connection...
3.
Bosnic Z, Babic F, Wittlinger T, Anderkova V, Sahinovic I, Majnaric L
Med Sci Monit
. 2023 Oct;
29:e940128.
PMID: 37837182
BACKGROUND The cytokine IL-17A is emerging as a marker of chronic inflammation in cardio-metabolic conditions. This study aimed to identify relevant factors that in older primary care patients with type...
4.
Joseph P, Roy A, Lonn E, Stork S, Floras J, Mielniczuk L, et al.
JAMA
. 2023 May;
329(19):1650-1661.
PMID: 37191704
Importance: Most epidemiological studies of heart failure (HF) have been conducted in high-income countries with limited comparable data from middle- or low-income countries. Objective: To examine differences in HF etiology,...
5.
Bosnic Z, Babic F, Anderkova V, Stefanic M, Wittlinger T, Majnaric L
Int J Environ Res Public Health
. 2023 Feb;
20(4).
PMID: 36834391
Background: The role of the cytokine interleukin-37 (IL-37) has been recognized in reversing inflammation-mediated metabolic costs. The aim was to evaluate the clinical utility of this cytokine as a diagnostic...
6.
Wittlinger T, Bekic S, Guljas S, Perisa V, Volaric M, Majnaric L
Front Med (Lausanne)
. 2022 Nov;
9:989814.
PMID: 36388902
Background: Physical frailty and cognitive decline are two major consequences of aging and are often in older individuals, especially in those with multimorbidity. These two disorders are known to usually...
7.
Majnaric L, Bosnic Z, Stefanic M, Wittlinger T
Int J Mol Sci
. 2022 Jun;
23(12).
PMID: 35742902
Chronic inflammation is considered to be the main mechanism contributing to the development of age-related metabolic and vascular conditions. The phases of chronic inflammation that mediate the progression of target...
8.
Bosnic Z, Yildirim P, Babic F, Sahinovic I, Wittlinger T, Martinovic I, et al.
Healthcare (Basel)
. 2021 Dec;
9(12).
PMID: 34946413
Diabetes mellitus type 2 (DM2) is a complex disease associated with chronic inflammation, end-organ damage, and multiple comorbidities. Initiatives are emerging for a more personalized approach in managing DM2 patients....
9.
Wittlinger T, Schramm R, Bleiziffer S, Rudolph V, Gummert J, Deutsch M
Thorac Cardiovasc Surg
. 2021 Nov;
70(7):537-543.
PMID: 34808682
Coronary artery bypass grafting (CABG) is the recommended type of revascularization procedure in patients with left main or three-vessel disease and is considered an alternative when percutaneous coronary intervention is...
10.
Wittlinger T, Schwaab B, Voller H, Bongarth C, Heinze V, Eckrich K, et al.
J Cardiovasc Dev Dis
. 2021 Sep;
8(9).
PMID: 34564123
Background: Cardiac rehabilitation (CR) in patients with coronary heart disease (CHD) increases adherence to a healthy lifestyle and to secondary preventive medication. A notable example of such medication is lipid-lowering...